Victrex (LON:VCT – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at Jefferies Financial Group in a report issued on Tuesday,London Stock Exchange reports. They currently have a GBX 595 price target on the stock. Jefferies Financial Group’s price target points to a potential downside of 13.93% from the stock’s previous close.
Other analysts have also recently issued reports about the stock. Berenberg Bank reduced their target price on shares of Victrex from GBX 695 to GBX 600 and set a “hold” rating for the company in a report on Tuesday, June 9th. UBS Group reissued a “sell” rating and set a GBX 575 price objective on shares of Victrex in a report on Monday, May 11th. Canaccord Genuity Group cut Victrex to a “buy” rating and set a GBX 725 price objective on the stock. in a research note on Friday, May 15th. Finally, JPMorgan Chase & Co. cut their price target on shares of Victrex from GBX 725 to GBX 625 and set a “buy” rating on the stock in a report on Wednesday, March 18th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of GBX 662.86.
Read Our Latest Stock Report on VCT
Victrex Stock Up 18.8%
Victrex (LON:VCT – Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported GBX 17.20 earnings per share for the quarter. The business had revenue of £147.10 million during the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. As a group, sell-side analysts anticipate that Victrex will post 73.1078905 earnings per share for the current fiscal year.
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Read More
- Five stocks we like better than Victrex
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
